Peripheral artery disease and venous thromboembolic events after acute coronary syndrome: role of lipoprotein(a) and modification by alirocumab: prespecified analysis of the odyssey outcomes randomized clinical trial - Schwartz, G G; Steg, P G; Szarek, M (Circulation, 2020)